Oncogenic Pathway Combinations Predict Clinical Prognosis in Gastric Cancer
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Many solid cancers are known to exhibit a high degree of heterogeneity in their deregulation of different oncogenic pathways. We sought to identify major oncogenic pathways in gastric cancer (GC) with significant relationships to patient survival. Using gene expression signatures, we devised an in silico strategy to map patterns of oncogenic pathway activation in 301 primary gastric cancers, the second highest cause of global cancer mortality. We identified three oncogenic pathways (proliferation/stem cell, NF-kappaB, and Wnt/beta-catenin) deregulated in the majority (>70%) of gastric cancers. We functionally validated these pathway predictions in a panel of gastric cancer cell lines. Patient stratification by oncogenic pathway combinations showed reproducible and significant survival differences in multiple cohorts, suggesting that pathway interactions may play an important role in influencing disease behavior. Individual GCs can be successfully taxonomized by oncogenic pathway activity into biologically and clinically relevant subgroups. Predicting pathway activity by expression signatures thus permits the study of multiple cancer-related pathways interacting simultaneously in primary cancers, at a scale not currently achievable by other platforms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Global Cancer Statistics, 2002
Parkin, D. M., Bray, F., Ferlay, J., & Pisani, P. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.2.74 · Cited by 18,196
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519 · cited 1×
“, a known GC carcinogen, and aberrant NF-κB signaling has also been implicated in multiple inflammation-linked cancers such as GC”
BackgroundA collection of breast cancer cell lines for the study of functionally distinct cancer subtypes
Neve, R. M., Chin, K., Fridlyand, J., Yeh, J., Baehner, F. L., Fevr, T., Clark, L., Bayani, N., Coppe, J.-P., Tong, F., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.10.008 · Cited by 3,188
Oncogenic pathway signatures in human cancers as a guide to targeted therapies
Bild, A. H., Yao, G., Chang, J. T., Wang, Q., Potti, A., Chasse, D., Joshi, M.-B., Harpole, D., Lancaster, J. M., Berchuck, A., et al. (2006) · Nature · doi:10.1038/nature04296 · Cited by 2,032
Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.
Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., & Miyamoto, S. (1995) · Genes & Development · doi:10.1101/gad.9.22.2723 · Cited by 1,724
"Stemness": Transcriptional Profiling of Embryonic and Adult Stem Cells
Ramalho-Santos, M., Yoon, S., Matsuzaki, Y., Mulligan, R. C., & Melton, D. A. (2002) · Science · doi:10.1126/science.1072530 · Cited by 1,709
Cited by
Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes
Cristescu, R., Lee, J., Nebozhyn, M., Kim, K.-M., Ting, J. C., Wong, S. S., Liu, J., Yue, Y. G., Wang, J., Yu, K., et al. (2015) · Nature Medicine · doi:10.1038/nm.3850 · Cited by 2,223
Self-citationDeng, N., Goh, L. K., Wang, H., Das, K., Tao, J., Tan, I. B., Zhang, S., Lee, M., Wu, J., Lim, K. H., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-301839 · Cited by 645
Self-citationZang, Z. J., Cutcutache, I., Poon, S. L., Zhang, S. L., McPherson, J. R., Tao, J., Rajasegaran, V., Heng, H. L., Deng, N., Gan, A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2246 · Cited by 616
Self-citationGenetics and Molecular Pathogenesis of Gastric Adenocarcinoma
Tan, P., & Yeoh, K.-G. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.05.059 · Cited by 492
Self-citationLei, Z., Tan, I. B., Das, K., Deng, N., Zouridis, H., Pattison, S., Chua, C., Feng, Z., Guan, Y. K., Ooi, C. H., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.05.010 · Cited by 458
Self-citationGastric cancer—molecular and clinical dimensions
Wadhwa, R., Song, S., Lee, J.-S., Yao, Y., Wei, Q., & Ajani, J. A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.170 · Cited by 423
Self-citationSun, T.-T., He, J., Liang, Q., Ren, L.-L., Yan, T.-T., Yu, T.-C., Tang, J.-Y., Bao, Y.-J., Hu, Y., Lin, Y., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0921 · Cited by 397
Yang, X.-Z., Cheng, T.-T., He, Q.-J., Lei, Z.-Y., Chi, J., Tang, Z., Liao, Q.-X., Zhang, H., Zeng, L.-S., & Cui, S.-Z. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0874-1 · Cited by 386
LncRNA GLCC1 promotes colorectal carcinogenesis and glucose metabolism by stabilizing c-Myc
Tang, J., Yan, T., Bao, Y., Shen, C., Yu, C., Zhu, X., Tian, X., Guo, F., Liang, Q., Liu, Q., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11447-8 · Cited by 372
Paradoxical Relationship between Chromosomal Instability and Survival Outcome in Cancer
Birkbak, N. J., Eklund, A. C., Li, Q., McClelland, S. E., Endesfelder, D., Tan, P., Tan, I. B., Richardson, A. L., Szallasi, Z., & Swanton, C. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3667 · Cited by 350
Self-citationLncRNA PVT1 promotes angiogenesis via activating the STAT3/VEGFA axis in gastric cancer
Zhao, J., Du, P., Cui, P., Qin, Y., Hu, C., Wu, J., Zhou, Z., Zhang, W., Qin, L., & Huang, G. (2018) · Oncogene · doi:10.1038/s41388-018-0250-z · Cited by 342
Self-citationAntimicrobial peptides and gut microbiota in homeostasis and pathology
Ostaff, M. J., Stange, E. F., & Wehkamp, J. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201773 · Cited by 329
Role of the Wnt/β-catenin pathway in gastric cancer: An in-depth literature review
Chiurillo, M. A. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.84 · Cited by 317
Molecular Classification of Gastric Cancer: A New Paradigm
Shah, M. A., Khanin, R., Tang, L., Janjigian, Y. Y., Klimstra, D. S., Gerdes, H., & Kelsen, D. P. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2203 · Cited by 311
STAT3-Driven Upregulation of TLR2 Promotes Gastric Tumorigenesis Independent of Tumor Inflammation
Tye, H., Kennedy, C. L., Najdovska, M., McLeod, L., McCormack, W., Hughes, N., Dev, A., Sievert, W., Ooi, C. H., Ishikawa, T.-O., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.010 · Cited by 273
Self-citationWang, R., Dang, M., Harada, K., Han, G., Wang, F., Pool Pizzi, M., Zhao, M., Tatlonghari, G., Zhang, S., Hao, D., et al. (2021) · Nature Medicine · doi:10.1038/s41591-020-1125-8 · Cited by 267
Microbiota effects on cancer: From risks to therapies
Rea, D., Coppola, G., Palma, G., Barbieri, A., Luciano, A., Del Prete, P., Rossetti, S., Berretta, M., Facchini, G., Perdonà, S., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24681 · Cited by 208
“The up-regulation of interleukin-17 in the gastric tissue and serums associated with a Th17 response, results in gastric tumor pathology induced in H. pylori mono-associated Mouse INS-GAS [33, 34].”
InfluentialRoylance, R., Endesfelder, D., Gorman, P., Burrell, R. A., Sander, J., Tomlinson, I., Hanby, A. M., Speirs, V., Richardson, A. L., Birkbak, N. J., et al. (2011) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-11-0343 · Cited by 175
“40 >50 y 170 (69) 60 (78) 50 (65) 39 (66) 21 (64) 50 y 76 (31) 17 (22) 27 (35) 20 (34) 12 (36) Grade (%) 1 46 (18) 17 (22) 19 (25) 8 (13) 2 (6) 0.”
MethodTRPV4 Regulates Breast Cancer Cell Extravasation, Stiffness and Actin Cortex
Lee, W. H., Choong, L. Y., Mon, N. N., Lu, S., Lin, Q., Pang, B., Yan, B., Krishna, V. S. R., Singh, H., Tan, T. Z., et al. (2016) · Scientific Reports · doi:10.1038/srep27903 · Cited by 125
Self-citationIntegrating genetic and gene expression evidence into genome-wide association analysis of gene sets
Xiong, Q., Ancona, N., Hauser, E. R., Mukherjee, S., & Furey, T. S. (2012) · Genome Research · doi:10.1101/gr.124370.111 · Cited by 103
Jiang, J., Ding, Y., Wu, M., Lyu, X., Wang, H., Chen, Y., Wang, H., & Teng, L. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.01765 · Cited by 52
“0 Array), with the former constituting 111 gastric cancer tissues and 21 normal gastric tissues (Submission date: Jan 16, 2014) while the latter included 200 primary gastric cancer tissues (Submission date: Mar 30, 2009) (12).”
BackgroundMethodYu, L., Wu, D., Gao, H., Balic, J. J., Tsykin, A., Han, T.-S., Liu, Y. D., Kennedy, C. L., Li, J. K., Mao, J. Q., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-2485 · Cited by 50
Self-citationChen, S., Zang, Y., Xu, B., Lu, B., Ma, R., Miao, P., & Chen, B. (2022) · Computational and Mathematical Methods in Medicine · doi:10.1155/2022/5844846 · Cited by 15
A methylation‐based mRNA signature predicts survival in patients with gastric cancer
Li, Y., Sun, R., Zhang, Y., Yuan, Y., & Miao, Y. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01374-w · Cited by 8
Metadata
- Authors
- Ooi, C. H., Ivanova, T., Wu, J., Lee, M., Tan, I. B., Tao, J., Ward, L., Koo, J. H., Gopalakrishnan, V., Zhu, Y., Cheng, L. L., Lee, J., Rha, S. Y., Chung, H. C., Ganesan, K., So, J., Soo, K. C., Lim, D., Chan, W. H., Wong, W. K., Bowtell, D., Yeoh, K. G., Grabsch, H., Boussioutas, A., & Tan, P.
- Venue
- PLoS Genetics
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-10-02
- Volume
- 5
- Issue
- 10
- Pages
- e1000676
- ISSN
- 1553-7390 (ISSN-L)
- 1553-7404
- OpenAlex
- W1562431437
- Cited by
- 447
- References
- 45
- FWCI
- 10.93
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.